Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Northfield Laboratories Inc.

www.northfieldlabs.com

Latest From Northfield Laboratories Inc.

NormOxys Inc.

The founders of NormOxys are working to commercialize molecules similar to those that give migratory birds the fortitude to fly thousands of miles. When the compound inositol pentaphosphate binds to the protein hemoglobin, its presence helps release up to three of the four oxygen molecules that hemoglobin picks up in the lungs and carries out to the body. NormOxys is betting that its lead candidate can help elevate oxygen levels in human tissues that lack it, and so become a treatment for a range of disorders, from heart failure to diabetic retinopathy, traumatic blood loss, and even cancer.
BioPharmaceutical Platform Technologies

2010 Scrip 100 - Survivors of the shakeout

Crunched credit wiped out many biotech firms in 2009, yet some emerged from the wreckage leaner and stronger. How did they do it, asks Dr Sukaina Virji-Jeganathan.

Metabolic Disorders Cancer

Northfield Labs files for bankruptcy protection

Northfield Laboratories has filed for bankruptcy protection after its red blood cell substitute PolyHeme was denied approval by the US FDA. The US firm said it will liquidate its assets in a chapter 11 bankruptcy filing.

Companies

FDA accepts Northfield's BLA for red blood cell substitute PolyHeme

The US FDAhas accepted Northfield Laboratories' BLA for its only product, a human haemoglobin-based red blood cell substitute named PolyHeme, for the treatment of urgent, large volume blood loss when a blood transfusion is required and red blood cells are not available.

Infectious Diseases Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Northfield Laboratories Inc.
  • Senior Management
  • Steven A Gould, MD, Chmn. & CEO
    Laurel A Omert, MD, CMO
  • Contact Info
  • Northfield Laboratories Inc.
    Phone: (847) 864-3500
    1560 Sherman Ave.
    Evanston, IL 60201-4422
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register